| 08.30 | Welcome coffee, registration |
Morning SessionChairs: Jérôme Cassayre, Syngenta and Thomas Heinz, Novartis |
|
| 08.55 | Opening, welcome Dr. Remo Gamboni, F. Hoffmann-La Roche |
| 09.00 | Dr. Silvio Roggo, Senior Investigator, Natural Products Chemistry, Novartis AG «Reengineering and Repurposing of Cyclosporins» |
| 09.30 | Dr. Marc Thommen, Head CMC, Polyphor Ltd, Allschwil, and Dr. Stefan Eissler, Bachem AG, Bubendorf «Murepavadin - A novel antibiotic overcoming bacterial resistance and its challenging manufacture on large scale» |
| 10.00 | Dr. Michael Levis, Siegfried AG «From Lab to Plant – achieving better process performance on scale using new lab technologies and data management tools» |
| 10.30 | Coffee Break |
| 11.00 | Dr. Christian Chapuis, Firmenich SA «Synthesis of Methyl Jasmonate and Analogues» |
| 11.30 | 4x Short Talks à 8min Dr. Andreas Hafner, BASF Schweiz AG, Basel
«Vision “24h daylight illumination in buildings"» Dr. Andreas Gloger, Philochem AG
«DNA-encoded chemical libraries» Dr. Christof Aellig, LONZA, Visp
«Lonza's advances in flow chemistry» Dr. Paul Hebeisen, PIQUR Therapeutics AG, Basel
«What a Difference a Dalton Makes. From the University Lab to PIQUR» |
Lunch and Poster Sessions |
|
| 12.10 | Lunch buffet |
| 12.45 | Poster sessions A (2nd and 3rd floor) and coffee |
| 13.30 | Poster sessions B (2nd and 3rd floor) and coffee |
Afternoon SessionChair: Olivier Baudoin, University of Basel |
|
| 14.20 | 4x Short Talks à 8min Dr. Craig Harris, Head of Research Synthesis, Nestlé Skin Health/ Galderma S.A., Lausanne
«Design and Synthesis of Novel Peptidomimetic Caspase I Inhibitors as a Novel Topical Treatment for Acne» Dr. Werner Bonrath, DSM Nutritional Products
«Future of Catalysis in Fine Chemical Industry» Dr. Thomas Fessard, Spirochem AG
«New trends and tactics in bioisosteric switch strategies» Dr. Vit Lellek, Cilag/ Johnson & Johnson
«From Process Development of a potent Cathepsin S-Inhibitor to efficient Syntheses of Pyrazoles» |
| 15.00 | Dr. Thomas Woltering and Dr. Jean-Michel Adam, F. Hoffmann-La Roche AG, Basel «BACE1 Inhibitor - from 12mg to 7kg: A Great Mix of Challenges, "Surprises" & Achievements» |
| 15.30 | Dr. Christoph Boss, Idorsia Pharmaceuticals Ltd., Allschwil «Discovery and Characterization of ACT-541468, an Orally Available, Brain Penetrant Dual Orexin Receptor Antagonist with Potent Sleep Promoting Properties» |
| 16.00 | Coffee Break |
| 16.30 | Dr. Clemens Lamberth, Syngenta Crop Protection AG, Stein (AG) «How Rarely Used Reactions enabled the Synthesis of Highly Active Fungicides» |
| 17.00 | Dr. Ralf Dümpelmann, BaselArea.Swiss: promoting and enabling innovation |
| 17.05 | Award ceremony for the best poster presentation 3x5' presentations of winners |
| 17.30 | Concluding Remarks: Dr. Alain De Mesmaeker, Syngenta / SCS President Aperitif and Networking; meet the exhibitors and BaselArea.Swiss |
Free admission for SCS members. However, online registration until October 12 is mandatory.
CHF 50.00 for non-SCS members.
Call for Abstracts for Poster Presentations
Please register and apply for a poster presentation until August 19, 2018
